Goldberg Joel S 4
4 · REVVITY, INC. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
REVVITY (RVTY) Joel Goldberg Sells Shares After Option Exercise
What Happened
Joel S. Goldberg, Senior Vice President, Administration, General Counsel and Secretary of Revvity (RVTY), exercised stock options and immediately sold the resulting shares. On Feb 5, 2026 he exercised 12,717 shares at $92.09 (cost ≈ $1,171,109) and sold those 12,717 shares in multiple open-market transactions on Feb 5 for roughly $1.27M. On Feb 4, 2026 he also surrendered 869 shares to satisfy tax withholding on RSU vesting (≈ $87,882), and received RSU awards totaling 24,810 shares (6,427 + 18,383) that are scheduled to vest over three years.
Key Details
- Transaction dates: Feb 4–5, 2026; Form 4 filed Feb 6, 2026 (timely).
- Option exercise: 12,717 shares exercised at $92.09 = $1,171,109 (Feb 5).
- Open-market sales: 12,717 shares sold on Feb 5 in multiple trades at prices around $99–$103, total ≈ $1,274,357.
- Tax withholding: 869 RSU shares surrendered on Feb 4 to cover taxes (≈ $87,882).
- Grants: 24,810 RSU award shares reported on Feb 4 (6,427 + 18,383), vesting in three equal annual installments per footnotes.
- Sales executed pursuant to a 10b5-1 trading plan adopted Feb 6, 2025 (footnote).
- Ownership after the transactions is not specified in the provided excerpt.
- Footnotes clarify vesting schedules and that the RSU surrender satisfied withholding obligations.
Context
- This was effectively a cashless exercise: options were exercised and the same shares were sold in the open market on the same day. That is a common way for insiders to cover exercise costs and taxes.
- The filing is factual and does not indicate motivation; sales were made under a prearranged 10b5-1 plan and RSU vesting/tax withholding occurred as part of routine compensation administration.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-02-04$101.13/sh−869$87,882→ 36,820 total - Award
Common Stock
[F3]2026-02-04+6,427→ 43,247 total - Exercise/Conversion
Common Stock
2026-02-05$92.09/sh+12,717$1,171,109→ 55,964 total - Sale
Common Stock
[F4][F5]2026-02-05$99.47/sh−6,424$638,995→ 49,540 total - Sale
Common Stock
[F4][F6]2026-02-05$100.50/sh−3,544$356,172→ 45,996 total - Sale
Common Stock
[F4][F7]2026-02-05$101.33/sh−2,217$224,649→ 43,779 total - Sale
Common Stock
[F4][F8]2026-02-05$102.52/sh−532$54,541→ 43,247 total - Award
NQ Stock Option (right to buy)
[F10]2026-02-04+18,383→ 18,383 totalExercise: $103.39Exp: 2033-02-04→ Common Stock (18,383 underlying) - Exercise/Conversion
NQ Stock Option (right to buy)
[F11]2026-02-05−12,717→ 0 totalExercise: $92.09Exp: 2026-02-05→ Common Stock (12,717 underlying)
- 63,709(indirect: By Trust)
Common Stock
[F9]
Footnotes (11)
- [F1]The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F10]This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F11]This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
- [F2]These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.
- [F3]Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F4]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025.
- [F5]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.97. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.98 to $100.95. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.98 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F9]Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.